Rowan ranked high for R&D in the region

Rowan ranked high for R&D in the region

Share

The Greater Philadelphia Region Life Sciences Report ranks Rowan University seventh among 19 colleges and universities in the region in R&D expenditures related to life sciences, third among the public institutions.

The ranking is based on 2014 figures from the National Science Foundation and includes funds spent on biological sciences, chemical engineering, chemistry, medical sciences and other life sciences. Rowan spent $4.9 million, with the largest amount in the medical sciences ($2.5 million). The numbers reflect R&D spending supported by the National Institutes of Health and other federal agencies, according to the report.

The report noted, “One of the (Greater Philadelphia Region’s) primary competitive advantages for the Life Sciences sector is the excellence, size, and diversity of its colleges and universities. There are more than 100 post-secondary institutions located in the GPR.” The GPR includes 11 counties in southeastern Pennsylvania, southern New Jersey and northern Delaware.

Partners involved in the publication are: Ben Franklin Technology Partners of Southeastern Pennsylvania, BioAdvance, CEO Council for Growth, The Chamber of Commerce for Greater Philadelphia, EY, IHS-Markit, Life Sciences Pennsylvania, Philadelphia Alliance for Capital and Technologies, Philadelphia Works, Select Greater Philadelphia Council and University City Science Center.

The report focuses on trends and highlights from January 2011 to June 2016.

Dr. Shreekanth Mandayam, vice president for Research, said, “The ranking reflects Rowan’s commitment to the life sciences and funders’ recognition of the exceptional work being done by our faculty and students in these fields.”